Cargando…
Insights into the elimination of vivax malaria in China
BACKGROUND: Malaria is caused by multiple parasitic species of the genus Plasmodium. Plasmodium vivax is the most geographically widespread and poses challenges in elimination due to its unique biological and epidemiological characteristics. The aim of study was to highlight the practices and experi...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10025774/ https://www.ncbi.nlm.nih.gov/pubmed/36941701 http://dx.doi.org/10.1186/s40249-023-01077-0 |
_version_ | 1784909409605910528 |
---|---|
author | Huang, Fang Zhang, Li Xia, Zhi-Gui |
author_facet | Huang, Fang Zhang, Li Xia, Zhi-Gui |
author_sort | Huang, Fang |
collection | PubMed |
description | BACKGROUND: Malaria is caused by multiple parasitic species of the genus Plasmodium. Plasmodium vivax is the most geographically widespread and poses challenges in elimination due to its unique biological and epidemiological characteristics. The aim of study was to highlight the practices and experience targeting vivax malaria control and elimination in China. MAIN BODY: P. vivax malaria was historically endemic in more than 70% of counties in China, with reported vivax malaria cases as high as 26 million a year. After around 70 years of effort, China was certified as malaria-free in June of 2021. The key insights into China’s vivax malaria control and elimination were offered, including radical cure strategies, comprehensive but adaptive strategies targeting species of Plasmodium and Anopheles, mass drug administration, and case-/focus-centred surveillance and response systems. CONCLUSION: The complete global eradication of P. vivax and eventually malaria will be more difficult, and China’s practices and experience could be a valuable reference in this campaign. GRAPHICAL ABSTRACT: [Image: see text] |
format | Online Article Text |
id | pubmed-10025774 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-100257742023-03-21 Insights into the elimination of vivax malaria in China Huang, Fang Zhang, Li Xia, Zhi-Gui Infect Dis Poverty Commentary BACKGROUND: Malaria is caused by multiple parasitic species of the genus Plasmodium. Plasmodium vivax is the most geographically widespread and poses challenges in elimination due to its unique biological and epidemiological characteristics. The aim of study was to highlight the practices and experience targeting vivax malaria control and elimination in China. MAIN BODY: P. vivax malaria was historically endemic in more than 70% of counties in China, with reported vivax malaria cases as high as 26 million a year. After around 70 years of effort, China was certified as malaria-free in June of 2021. The key insights into China’s vivax malaria control and elimination were offered, including radical cure strategies, comprehensive but adaptive strategies targeting species of Plasmodium and Anopheles, mass drug administration, and case-/focus-centred surveillance and response systems. CONCLUSION: The complete global eradication of P. vivax and eventually malaria will be more difficult, and China’s practices and experience could be a valuable reference in this campaign. GRAPHICAL ABSTRACT: [Image: see text] BioMed Central 2023-03-20 /pmc/articles/PMC10025774/ /pubmed/36941701 http://dx.doi.org/10.1186/s40249-023-01077-0 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Commentary Huang, Fang Zhang, Li Xia, Zhi-Gui Insights into the elimination of vivax malaria in China |
title | Insights into the elimination of vivax malaria in China |
title_full | Insights into the elimination of vivax malaria in China |
title_fullStr | Insights into the elimination of vivax malaria in China |
title_full_unstemmed | Insights into the elimination of vivax malaria in China |
title_short | Insights into the elimination of vivax malaria in China |
title_sort | insights into the elimination of vivax malaria in china |
topic | Commentary |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10025774/ https://www.ncbi.nlm.nih.gov/pubmed/36941701 http://dx.doi.org/10.1186/s40249-023-01077-0 |
work_keys_str_mv | AT huangfang insightsintotheeliminationofvivaxmalariainchina AT zhangli insightsintotheeliminationofvivaxmalariainchina AT xiazhigui insightsintotheeliminationofvivaxmalariainchina |